about
Quantification of mitochondrial morphology in neurites of dopaminergic neurons using multiple parametersOlfactory deficits in an alpha-synuclein fly model of Parkinson's diseaseA loss of Pdxk model of Parkinson disease in Drosophila can be suppressed by BuffyBax-inhibitor-1 knockdown phenotypes are suppressed by Buffy and exacerbate degeneration in a Drosophila model of Parkinson disease.Loss of porin function in dopaminergic neurons of Drosophila is suppressed by Buffy.Bcl-2 homologue Debcl enhances α-synuclein-induced phenotypes in Drosophila.The Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila.Developmental toxicity assays using the Drosophila model.An automated climbing apparatus to measure chemotherapy-induced neurotoxicity in Drosophila melanogaster.Drosophila models of Parkinson's disease: discovering relevant pathways and novel therapeutic strategies.Drosophila melanogaster: a new model to study cisplatin-induced neurotoxicity.A gain-of-function screen to identify genes that reduce lifespan in the adult of Drosophila melanogaster.A Drosophila model for genetic analysis of influenza viral/host interactions.Drosophila models of proteinopathies: the little fly that could.Mitochondrial dysfunction in genetic animal models of Parkinson's diseaseA novel, sensitive assay for behavioral defects in Parkinson's disease model DrosophilaUnderstanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy.Kinase signaling dysfunction in Parkinson's disease: a reverse genetic approach in Drosophila.The bad, the good, and the ugly about oxidative stress.Using Drosophila models of neurodegenerative diseases for drug discovery.SUMO and Parkinson's disease.Ayurvedic Amalaki Rasayana promotes improved stress tolerance and thus has anti-aging effects in Drosophila melanogaster.Limitations of animal models of Parkinson's disease.Classification of Parkinson's Disease Genotypes in Drosophila Using Spatiotemporal Profiling of Visionparkin-induced defects in neurophysiology and locomotion are generated by metabolic dysfunction and not oxidative stress.A correlation of reactive oxygen species accumulation by depletion of superoxide dismutases with age-dependent impairment in the nervous system and muscles of Drosophila adults.Copper and Zinc Homeostasis: Lessons from Drosophila melanogaster.6-OHDA-Lesioned Adult Zebrafish as a Useful Parkinson's Disease Model for Dopaminergic Neuroregeneration.Analysis of dopaminergic neuronal dysfunction in genetic and toxin-induced models of Parkinson's disease in Drosophila.The HtrA2 Drosophila model of Parkinson's disease is suppressed by the pro-survival Bcl-2 Buffy.Life span and locomotor activity modification by glucose and polyphenols in Drosophila melanogaster chronically exposed to oxidative stress-stimuli: implications in Parkinson's disease.The role of calcium channel blockers and resveratrol in the prevention of paraquat-induced parkinsonism in Drosophila melanogaster: a locomotor analysis.Synphilin suppresses α-synuclein neurotoxicity in a Parkinson's disease Drosophila model.
P2860
Q28272173-F98A6825-67CA-4BA1-A6A9-4625DE17D8BFQ28539195-19C6E330-E382-46B3-B388-B58EF3BC011DQ30352332-5C492A10-B096-4616-9EC1-452A80C56757Q30353961-4A2A52A3-5286-4E1A-BEEB-95E5B3A902B3Q30355095-FAC236DD-DE17-42F0-B71E-1446D7F6AA1AQ30356412-8F5B97F4-D6B9-459A-A0C6-9DBB7DC57A30Q30359012-A21A07B9-D616-4985-A5CB-2320330B1119Q33677855-6E1273AC-5DFD-4529-A77B-8AA0F87581D2Q33728158-EB46F1CC-6FA7-4570-ACEA-22714354E0C8Q34787767-EA7E56FD-C7F1-4DB7-A3A3-99CBBE796099Q35090211-55AF2B6A-8901-4583-AAE7-756AFA109587Q35150127-86AA2BB0-36BD-4956-8EC1-D960FF824C42Q35297733-D641E87E-A74F-4CCA-805C-F0DEF20EAA4CQ35791494-F3505117-6EB1-49D5-8209-964F78607821Q35799109-1512C041-4AC1-4BAF-91C6-EE9D63311E39Q36135025-B87CF37F-2674-4715-B984-2991615F5C13Q37775037-8F12E9F1-642F-4BC6-8E0A-A8109DED5EF5Q38001018-C991A97B-559C-49D0-B281-673186959571Q38012450-002B2B0A-238F-4E27-A48E-104D35674A5BQ38014579-3E34959B-D1CB-422F-A864-FB453A38E2F2Q38131751-B2FBCE6A-1FCB-4486-A6A9-1BFF0C5B86E4Q39102702-8CE73F5E-4DAD-4A3C-84E5-D9A947306199Q41488512-1F5FA271-6B41-4C0F-BE60-601A3E198DBCQ41863382-6472E59B-D2E5-4BB0-85D0-1D3CE16258F7Q42564301-8426A0AE-CA0A-4295-B8F9-390865018BE5Q46754878-D2862419-C5AC-45C5-9B78-85307CB457DBQ47408660-A04EEE95-21C8-4DE7-BFB3-A76C2FBAD157Q48196426-2BE63993-E891-433E-8F92-FC3B9E4E3576Q50452745-99479559-703F-4675-A4A3-83C5673571A1Q51325327-4D873E5F-4A5D-4603-BF25-228B6CE2E214Q52717936-13D59B4D-C5E9-4B0E-8833-B68294B911CAQ52719394-63ED4ACD-00C6-4903-917C-B5D3378E7638Q54372671-6E13C289-96D9-419D-8181-54FD92C47692
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Modelling Parkinson's disease in Drosophila.
@en
Modelling Parkinson's disease in Drosophila.
@nl
type
label
Modelling Parkinson's disease in Drosophila.
@en
Modelling Parkinson's disease in Drosophila.
@nl
prefLabel
Modelling Parkinson's disease in Drosophila.
@en
Modelling Parkinson's disease in Drosophila.
@nl
P2093
P2860
P1476
Modelling Parkinson's disease in Drosophila.
@en
P2093
Florian Bayersdorfer
Florian Gmeiner
José A Botella
Stephan Schneuwly
P2860
P2888
P304
P356
10.1007/S12017-009-8098-6
P577
2009-10-24T00:00:00Z